DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,616 filers reported holding DANAHER CORPORATION in Q3 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $35,317,000 | +12.2% | 116,005 | -1.1% | 2.30% | +12.0% |
| Q2 2021 | $31,469,000 | +19.6% | 117,264 | +0.3% | 2.06% | +11.0% |
| Q1 2021 | $26,309,000 | -0.9% | 116,889 | -2.2% | 1.85% | -8.7% |
| Q4 2020 | $26,560,000 | +1.7% | 119,563 | -1.5% | 2.03% | -10.4% |
| Q3 2020 | $26,125,000 | -2.0% | 121,324 | -19.5% | 2.26% | +3.8% |
| Q2 2020 | $26,659,000 | +25.5% | 150,763 | -1.8% | 2.18% | +8.9% |
| Q1 2020 | $21,244,000 | -45.6% | 153,486 | -39.6% | 2.00% | -29.0% |
| Q4 2019 | $39,019,000 | +6.5% | 254,227 | +0.3% | 2.82% | -3.3% |
| Q3 2019 | $36,626,000 | +0.4% | 253,590 | -0.6% | 2.92% | -3.3% |
| Q2 2019 | $36,471,000 | +7.4% | 255,182 | -0.8% | 3.02% | +4.1% |
| Q1 2019 | $33,971,000 | +29.5% | 257,315 | +1.1% | 2.90% | +16.0% |
| Q4 2018 | $26,240,000 | -4.8% | 254,462 | +0.4% | 2.50% | +7.0% |
| Q3 2018 | $27,550,000 | +10.7% | 253,541 | +0.5% | 2.33% | +3.5% |
| Q2 2018 | $24,887,000 | -0.6% | 252,199 | -1.3% | 2.25% | -3.2% |
| Q1 2018 | $25,028,000 | +4.8% | 255,628 | -0.6% | 2.33% | +9.2% |
| Q4 2017 | $23,874,000 | +8.3% | 257,208 | +0.1% | 2.13% | +1.4% |
| Q3 2017 | $22,037,000 | +2.1% | 256,897 | +0.4% | 2.10% | -0.4% |
| Q2 2017 | $21,592,000 | -0.4% | 255,861 | +0.9% | 2.11% | -6.0% |
| Q1 2017 | $21,681,000 | +11.7% | 253,493 | +1.7% | 2.25% | +7.5% |
| Q4 2016 | $19,405,000 | -3.1% | 249,289 | -2.4% | 2.09% | -4.0% |
| Q3 2016 | $20,020,000 | -21.2% | 255,392 | +1.5% | 2.18% | -24.1% |
| Q2 2016 | $25,418,000 | +7.6% | 251,660 | +1.0% | 2.87% | +5.1% |
| Q1 2016 | $23,628,000 | +0.3% | 249,084 | -1.8% | 2.73% | -2.4% |
| Q4 2015 | $23,562,000 | +9.6% | 253,683 | +0.5% | 2.79% | +1.4% |
| Q3 2015 | $21,500,000 | -0.4% | 252,316 | +0.1% | 2.76% | +10.4% |
| Q2 2015 | $21,577,000 | +1.5% | 252,094 | +0.7% | 2.50% | +2.3% |
| Q1 2015 | $21,255,000 | -0.2% | 250,354 | +0.7% | 2.44% | -1.7% |
| Q4 2014 | $21,308,000 | +17.8% | 248,606 | +4.4% | 2.48% | +5.5% |
| Q3 2014 | $18,085,000 | -2.4% | 238,023 | +1.1% | 2.35% | -1.1% |
| Q2 2014 | $18,528,000 | +5.2% | 235,337 | +0.3% | 2.38% | -1.4% |
| Q1 2014 | $17,604,000 | -1.9% | 234,714 | +1.0% | 2.41% | -3.3% |
| Q4 2013 | $17,941,000 | +14.2% | 232,391 | +2.6% | 2.50% | -0.4% |
| Q3 2013 | $15,707,000 | +10.6% | 226,581 | +1.0% | 2.50% | +8.0% |
| Q2 2013 | $14,201,000 | – | 224,351 | – | 2.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |